TrialNature communications2025

Glucagon-like peptide-1 receptor agonist in large vessel occlusion treated by reperfusion therapy-a phase 2 randomized trial.

Hao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.